Following Health Canada's approval, Light AI and Emergo by UL collaborate to speed up regulatory submissions for its AI-powered diagnostics platform.

A top regulatory compliance consulting business with a focus on the medical devices sector, Emergo by UL, has partnered with Light AI, a healthcare technology startup located in Vancouver. As Light AI develops its AI-powered diagnostics platform for disease detection using smartphone photos, with a current focus on Group A Streptococcus, this collaboration represents a significant turning point in the company's commercialization path.

In order to establish a worldwide regulatory approach, Emergo by UL will first help Light AI with regulatory filings to Health Canada. CEO Peter Whitehead was excited by the partnership, highlighting Emergo by UL's proficiency in negotiating intricate regulatory environments and growing Light AI's global market presence.

Emergo by UL is expected to be a key component of Light AI's growth initiatives due to its vast experience in medical device registration, regulatory planning, ISO 13485 compliance, and post-market surveillance. The collaboration demonstrates Light AI's dedication to maintaining regulatory excellence as it expands its AI-powered diagnostic products into international markets.